AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31228136 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight Colorectal Anastomosis (SCA)
Number of subjects: 336
Study 28859790 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 116
Study 28859790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 28859790 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro-B-type natriuretic peptide
Number of subjects: 116
Study 28859790 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 116
Study 24913131 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL-PDT using 0.5% 5-aminolevulinic acid liposomal spray
Number of subjects: 0
Study 24913131 — intervention group
Group type: COMPARATOR
Intervention: Long pulsed Nd:YAG laser (LPNY)
Number of subjects: 0
Study 23307112 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drink containing 1.3 × 10(10) CFU Lactobacillus casei Shirota (LcS)
Number of subjects: 30
Study 23307112 — intervention group
Group type: COMPARATOR
Intervention: Skimmed milk (placebo)
Number of subjects: 30
Study 20847562 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral budesonide
Number of subjects: 139
Study 20847562 — intervention group
Group type: EXPERIMENTAL
Intervention: Microalbuminuria presence during relapse
Number of subjects: 139
Study 20847562 — intervention group
Group type: EXPERIMENTAL
Intervention: Microalbuminuria
Number of subjects: 139
Study 18269155 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-Bowman's keratomileusis (SBK)
Number of subjects: 50
Study 18269155 — intervention group
Group type: COMPARATOR
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 50
Study 16772251 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised home-based aerobic and progressive resistance training
Number of subjects: 40
Study 16772251 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 15472496 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonist
Number of subjects: 1086
Study 15472496 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme
Number of subjects: 1086
Study 15472496 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker
Number of subjects: 1086
Study 15472496 — intervention group
Group type: EXPERIMENTAL
Intervention: More-intensive BP-lowering group
Number of subjects: 1086
Study 15472496 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-intensive BP-lowering group
Number of subjects: 1086
Study 11379373 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary beverage containing isoflavones
Number of subjects: 24
Study 11379373 — intervention group
Group type: COMPARATOR
Intervention: Isoflavone-free, isocaloric placebo preparation
Number of subjects: 24
Study 9281212 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with faecal occult-blood tests (Hemoccult-II) every two years for 10 years
Number of subjects: 60933
Study 9281212 — intervention group
Group type: COMPARATOR
Intervention: Control group (unscreened)
Number of subjects: 60933
Study 8299854 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin 40 mg twice daily for 12 weeks
Number of subjects: 25
Study 8299854 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg once daily for 12 weeks
Number of subjects: 25
Study 8299854 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin plus Enalapril (both at original dosage) for 12 weeks
Number of subjects: 25
Study 3526267 — intervention group
Group type: EXPERIMENTAL
Intervention: Early physical therapy
Number of subjects: 134
Study 3526267 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow‐up care
Number of subjects: 134
Study 3526267 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (infants weighing less than 750 g at birth)
Number of subjects: 134
Study 31987962 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR with DIL boost (35 Gy to prostate, 25 Gy to pelvis, 50 Gy to DIL in 5 fractions)
Number of subjects: 60
Study 31987962 — intervention group
Group type: COMPARATOR
Intervention: SABR without DIL boost (40 Gy to prostate, 25 Gy to pelvis in 5 fractions)
Number of subjects: 60
Study 31987962 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR with DIL boost
Number of subjects: 60
Study 31987962 — intervention group
Group type: COMPARATOR
Intervention: SABR without DIL boost
Number of subjects: 60
Study 28834191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with fractional CO2 laser and PRP
Number of subjects: 80
Study 28834191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with fractional CO2 laser and NB-UVB
Number of subjects: 80
Study 28834191 — intervention group
Group type: COMPARATOR
Intervention: Fractional CO2 laser alone
Number of subjects: 80
Study 28834191 — intervention group
Group type: COMPARATOR
Intervention: PRP alone
Number of subjects: 80
Study 27716149 — intervention group
Group type: EXPERIMENTAL
Intervention: AST-120 (9 g/day)
Number of subjects: 583
Study 27716149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 583
Study 24179987 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic oscillating diamond burs
Number of subjects: 56
Study 24179987 — intervention group
Group type: COMPARATOR
Intervention: High-speed rotating diamond burs
Number of subjects: 56
Study 22094492 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4))
Number of subjects: 87
Study 22094492 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 87
Study 20482537 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery Doppler test combined with aspirin treatment
Number of subjects: 0
Study 18684084 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH
Number of subjects: 238
Study 18684084 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN
Number of subjects: 238
Study 18684084 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH-ALN
Number of subjects: 238
Study 18684084 — intervention group
Group type: EXPERIMENTAL
Intervention: CMB-ALN
Number of subjects: 238
Study 18684084 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN-ALN
Number of subjects: 238
Study 18684084 — intervention group
Group type: COMPARATOR
Intervention: PTH-PLB
Number of subjects: 238
Study 16026136 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic strain Enterococcus faecium M-74 (2x10^9 CFU) plus 50 microg of selenium, administered daily for 56 weeks
Number of subjects: 43
Study 16026136 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 43
Study 12488294 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 1.0 mg once daily
Number of subjects: 157
Study 12488294 — intervention group
Group type: COMPARATOR
Intervention: Fadrozole 1.0 mg twice daily
Number of subjects: 157
Study 14635294 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 10
Study 14635294 — intervention group
Group type: EXPERIMENTAL
Intervention: Range of motion/muscle strengthening (ROM/MS) exercise
Number of subjects: 10
Study 9093891 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysulphone low-flux dialyzers (F6HPS) rinsed with 1000 ml of saline plus 2000 IU of heparin
Number of subjects: 16
Study 9093891 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysulphone high-flux dialyzers (F6OS) rinsed with 1000 ml of saline plus 2000 IU of heparin
Number of subjects: 16
Study 9093891 — intervention group
Group type: COMPARATOR
Intervention: Both groups rinsed with 500 ml of saline without heparin
Number of subjects: 16
Study 8475360 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone treatment
Number of subjects: 190
Study 8475360 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 190
Study 2946981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 33
Study 2946981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 31722605 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 803
Study 31722605 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy
Number of subjects: 803
Study 31722605 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy plus radiotherapy
Number of subjects: 803
Study 31722605 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy plus radiotherapy and hormone therapy
Number of subjects: 803
Study 29655670 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-second handrub application
Number of subjects: 20
Study 29655670 — intervention group
Group type: COMPARATOR
Intervention: 30-second handrub application
Number of subjects: 20
Study 29655670 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained volunteers
Number of subjects: 20
Study 29655670 — intervention group
Group type: COMPARATOR
Intervention: Untrained volunteers
Number of subjects: 20
Study 27278130 — intervention group
Group type: EXPERIMENTAL
Intervention: QuinteT Recruitment Intervention (QRI)
Number of subjects: 0
Study 27278130 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of QRI into feasibility/pilot or main phase of RCT
Number of subjects: 0
Study 27278130 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of QRI to ongoing RCTs experiencing recruitment shortfalls
Number of subjects: 0
Study 24790019 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (n = 15)
Number of subjects: 29
Study 24790019 — intervention group
Group type: COMPARATOR
Intervention: Reference group (n = 14)
Number of subjects: 29
Study 22553930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 136
Study 20977015 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training program
Number of subjects: 68
Study 20977015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study 18753076 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous propofol infusion via the common carotid artery (IC group, n=20)
Number of subjects: 40
Study 18753076 — intervention group
Group type: COMPARATOR
Intervention: Intravenous propofol infusion via the median cubital vein (IV group, n=20)
Number of subjects: 40
Study 15358623 — intervention group
Group type: EXPERIMENTAL
Intervention: VKORC1 1173CC genotype
Number of subjects: 147
Study 15358623 — intervention group
Group type: COMPARATOR
Intervention: VKORC1 CT genotype
Number of subjects: 147
Study 15358623 — intervention group
Group type: COMPARATOR
Intervention: VKORC1 TT genotype
Number of subjects: 147
Study 12602461 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol
Number of subjects: 19
Study 9651125 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 0
Study 9651125 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 0
Study 7702019 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactating women
Number of subjects: 37
Study 7702019 — intervention group
Group type: COMPARATOR
Intervention: Nonlactating women and never pregnant women using oral contraceptives
Number of subjects: 37
Study 3402100 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical trimming of the inferior turbinates
Number of subjects: 18
Study 3402100 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior trimming of the inferior turbinates
Number of subjects: 18
Study 31628698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/day
Number of subjects: 493
Study 31628698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 3.0 mg/day
Number of subjects: 493
Study 31628698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 493
Study 30622590 — intervention group
Group type: EXPERIMENTAL
Intervention: Hou Gu Mi Xi (HGMX)
Number of subjects: 0
Study 30622590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28285121 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored, progressive, multidomain physical rehabilitation intervention
Number of subjects: 27
Study 25801579 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient uterine polypectomy under local anaesthetic
Number of subjects: 507
Study 25801579 — intervention group
Group type: COMPARATOR
Intervention: Inpatient uterine polypectomy under general anaesthesia
Number of subjects: 507
Study 23852067 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-reinforced resin bonded bridge
Number of subjects: 23
Study 23852067 — intervention group
Group type: COMPARATOR
Intervention: Removable partial denture
Number of subjects: 23
Study 23852067 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study 22001875 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted 2.5 μg RRV vaccine
Number of subjects: 382
Study 22001875 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccine formulations and doses
Number of subjects: 382
Study 19497765 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 36
Study 19497765 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (group S)
Number of subjects: 36
Study 17121639 — intervention group
Group type: EXPERIMENTAL
Intervention: Light resistance training (15-week intervention period, average training time of 5 min/working day, 25 min/week)
Number of subjects: 90
Study 17121639 — intervention group
Group type: COMPARATOR
Intervention: No training and no guidance (15-week control period)
Number of subjects: 90
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene cream
Number of subjects: 253
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene and tretinoin microsponge gels
Number of subjects: 253
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene cream and adapalene creams
Number of subjects: 253
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene gel
Number of subjects: 253
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower retinoid concentrations
Number of subjects: 253
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Vehicle (gel vs cream)
Number of subjects: 253
Study 15624747 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal skin
Number of subjects: 253
Study 11380642 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 2500
Study 11380642 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan (various doses 2-150 mg)
Number of subjects: 2500
Study 11380642 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan
Number of subjects: 2500
Study 9399190 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistency‐gradated diet
Number of subjects: 14
Study 9399190 — intervention group
Group type: COMPARATOR
Intervention: Control group (ate as they wished)
Number of subjects: 14
Study 7956991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine flour meal
Number of subjects: 10
Study 7956991 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse flour meal
Number of subjects: 10
Study 7956991 — intervention group
Group type: EXPERIMENTAL
Intervention: Cracked grain meal
Number of subjects: 10
Study 7956991 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain meal
Number of subjects: 10
Study 3902590 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 0.5 mg/kg/day plus a normal diet
Number of subjects: 16
Study 3902590 — intervention group
Group type: COMPARATOR
Intervention: Elemental diet plus oral framycetin, colistin and nystatin
Number of subjects: 16
Study 30086036 — intervention group
Group type: EXPERIMENTAL
Intervention: Plate Fixation (PF)
Number of subjects: 160
Study 30086036 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative Treatment (NOT)
Number of subjects: 160
Study 27656477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Fluticasone propionate aqueous nasal spray
Number of subjects: 120
Study 27656477 — intervention group
Group type: COMPARATOR
Intervention: Oral Montelukast
Number of subjects: 120
Study 24901723 — intervention group
Group type: EXPERIMENTAL
Intervention: Total thyroidectomy
Number of subjects: 108
Study 24901723 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy
Number of subjects: 108
Study 24901723 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 108
Study 24901723 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 108
Study 22496084 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 148
Study 22496084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 20549654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol
Number of subjects: 39
Study 20549654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 19192656 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin (lipoplatin)
Number of subjects: 46
Study 19192656 — intervention group
Group type: COMPARATOR
Intervention: Conventional cisplatin
Number of subjects: 46
Study 19192656 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin with 5-fluorouracil (5-FU)
Number of subjects: 46
Study 19192656 — intervention group
Group type: COMPARATOR
Intervention: Conventional cisplatin with 5-fluorouracil (5-FU)
Number of subjects: 46
Study 17499304 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure (relaxation group)
Number of subjects: 100
Study 17499304 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (sham treated group)
Number of subjects: 100
Study 17499304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 15496623 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 545
Study 15496623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 545
Study 10871977 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (physician, nurse, and social worker collaboration)
Number of subjects: 543
Study 10871977 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 543
Study 10871977 — intervention group
Group type: COMPARATOR
Intervention: Control group (care as usual)
Number of subjects: 543
Study 10871977 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 543
Study 9105140 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete immediate dentures
Number of subjects: 74
Study 9105140 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete immediate overdentures on lower canines with Dyna Direct magnetic attachments
Number of subjects: 74
Study 9105140 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete immediate overdentures on lower canines without Dyna Direct magnetic attachments
Number of subjects: 74
Study 1389734 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 55
Study 1389734 — intervention group
Group type: EXPERIMENTAL
Intervention: Power exercise training
Number of subjects: 55
Study 1389734 — intervention group
Group type: COMPARATOR
Intervention: Control group (no formal exercise training)
Number of subjects: 55
Study 4040019 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic evacuation of intracerebral hematomas using a suction-irrigation system and ultrasonic morcellement device
Number of subjects: 0
Study 4040019 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study 31838780 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention group
Number of subjects: 50
Study 31838780 — intervention group
Group type: COMPARATOR
Intervention: Emollient group
Number of subjects: 50
Study 31838780 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study 31323184 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (830-nm, 30-mW laser)
Number of subjects: 25
Study 31323184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 27416912 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib (10-min intravenous infusion; 20 mg/m2 on days 1 and 2 of cycle 1; 27 mg/m2 thereafter)
Number of subjects: 315
Study 27416912 — intervention group
Group type: COMPARATOR
Intervention: Low-dose corticosteroids (84 mg of dexamethasone or equivalent) with optional cyclophosphamide (1400 mg) for 28-day cycles
Number of subjects: 315
Study 27416912 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Number of subjects: 315
Study 27416912 — intervention group
Group type: COMPARATOR
Intervention: Control (low-dose corticosteroids with optional cyclophosphamide)
Number of subjects: 315
Study 27416912 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 315
Study 26464841 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychoeducational programme (8 continuous 90-minute sessions, 3 times a week)
Number of subjects: 74
Study 26464841 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study 23229881 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent exercise with active recovery (IEA)
Number of subjects: 24
Study 23229881 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent exercise with passive recovery (IEP)
Number of subjects: 24
Study 23229881 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study 21868187 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counselling to halve fat intake (Group 1)
Number of subjects: 107
Study 21868187 — intervention group
Group type: COMPARATOR
Intervention: Healthy eating advice only (Group 2)
Number of subjects: 107
Study 19241060 — intervention group
Group type: COMPARATOR
Intervention: Acute caffeine abstinence (placebo after 14 days of caffeine)
Number of subjects: 16
Study 19241060 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic caffeine administration (400 mg daily for > or =14 days)
Number of subjects: 16
Study 19241060 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute caffeine administration
Number of subjects: 16
Study 16838826 — intervention group
Group type: EXPERIMENTAL
Intervention: Taper-off program with group therapy
Number of subjects: 180
Study 16838826 — intervention group
Group type: EXPERIMENTAL
Intervention: Taper-off program without group therapy
Number of subjects: 180
Study 16838826 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower daily benzodiazepine dosage at the start of tapering off
Number of subjects: 180